Dilon Devices Announces FDA Approval of Updated Version of MarginProbe® with Feature Enhancements, Further Improving User-Friendly Experience for Surgeons
[vc_row][vc_column][vc_column_text] Medical Device update offers brighter screen, reduced size and emphasized alerts to improve ease-of-use for surgeons…
MarginProbe® Device is Able to Reduce Re-Excision Rate of Breast Conserving Surgery in Invasive and Pre-Invasive Breast Cancer Independent from Any Patient or Tumor Related Factors
[vc_row][vc_column][vc_column_text] San Antonio Breast Cancer Symposium – December 9-13, 2014 Blohmer JU (1,2), Tanko J (2), Groß…
Combined Experience at Three Breast Centers with Routine Use of an Intraoperative Margin Assessment Device Including Comparison to Historical Re-Excision Rates
Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported1 .
Combined Experience at Three Breast Centers with Routine Use of an Intraoperative Margin Assessment Device Including Comparison to Historical Re-Excision Rates.
Obtaining clear margins following a lumpectomy surgery for breast cancer is an important factor in the treatment of breast cancer while conserving the breast (BCS). Historically, high rates, 26%, of surgical interventions to obtain clear margins have been reported.
A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe® in Patients with Nonpalpable Breast Malignancies
[vc_row][vc_column][vc_column_text]Schnabel, F., Boolbol, S.K., Gittleman, M. et al. Ann Surg Oncol (2014) 21: 1589. doi:10.1245/s10434-014-3602-0 Abstract Background…
MarginProbe® Final Results of the German Post-Market Study in Breast Conserving Surgery of Ductal Carcinoma in Situ
[vc_row][vc_column][vc_column_text]Thill M1, Dittmer C2, Baumann K3, Friedrichs K4, Blohmer JU5. View the study by clicking here.[/vc_column_text][/vc_column][/vc_row]
The Impact of Intraoperative Margin Assessment with Adjunctive Use of MarginProbe® vs. Standard of Care, Dependence on Margin Threshold Definition
[vc_row][vc_column][vc_column_text]View Study[/vc_column_text][/vc_column][/vc_row]
Detection of Prostate Cancer by Radio-Frequency Near-Field Spectroscopy in Radical Prostatectomy Ex-Vivo Specimens
[vc_row][vc_column][vc_column_text]Dotan ZA1, Fridman E, Lindner A, Ramon J, Pode D, Bejar J, Kopolovic J, Pizov G, Sandbank…
MarginProbe®: Intraoperative Margin Assessment During Breast Conserving Surgery by Using Radiofrequency Spectroscopy; 2013
[vc_row][vc_column][vc_column_text]View Study[/vc_column_text][/vc_column][/vc_row]
MarginProbe® System Over 3 Times More Effective in Identifying “Cancer on the Margin” During Lumpectomy than Traditional Intraoperative Methods
[vc_row][vc_column][vc_column_text]Boston, Mass., January 2, 2013, /PRNewswire/ — Dilon Devices, Inc., announced today that its breakthrough intra-operative tissue…
Dilon Devices Announced Today that the MarginProbe® System Will Be Used at the Agaplesion Markus Hospital, in Frankfurt, Germany
[vc_row][vc_column][vc_column_text]Framingham, MA, September 27, 2012 – Dilon Devices announced today that the MarginProbe System will be used…
Dilon Devices, Inc., Announced Today that it has Received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration
[vc_row][vc_column][vc_column_text]Framingham, Mass., November 19, 2012 – Dilon Devices, Inc., announced today that it has received an Approvable…
How can we help?
Before you commit to a particular
course of treatment, talk to us.